Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

Share Price is delayed by 15 minutes
Get Live Data
164.40    0.00 (0.00%)
Bid:
162.80
Ask:
166.00
Spread: 3.20 (1.966%)
Market Cap: -
SAN Live PriceLast checked at - London Stock Exchange

Intraday Sant Uk.10te% Share Chart

Euro Medium Term Note Programme - Final Terms

28 Feb 2020 13:24

RNS Number : 5368E
Santander UK Group Holdings PLC
28 February 2020
 

 

SANTANDER UK GROUP HOLDINGS PLC

€30 BILLION EURO MEDIUM TERM NOTE PROGRAMME

PUBLICATION OF FINAL TERMS - SERIES B-5010

 

The following final terms (the Final Terms) are available for viewing:

 

Issue of EUR 750,000,000 Senior Fixed Rate Reset Notes due 2025 (ISIN XS2126058168) (Series B-5010) (the Notes), under the €30 billion Euro Medium Term Note programme of Santander UK Group Holdings plc and Santander UK plc (the Programme).

 

To view the full Final Terms document, please click on or paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/5368E_1-2020-2-28.pdf

 

A copy of the Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM. This website is not provided for, nor is it directed at, U.S. persons or persons in the United States. If you are a U.S. person, or you are viewing this page from the United States, you should exit this section of the website.

 

For further information, please contact:

 

Medium Term FundingSantander UK plc2 Triton SquareRegent's PlaceLondon NW1 3AN

Tel: +44 (0) 20 7756 7100

Email: mtf@santander.co.uk

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Final Terms and the base prospectus published in respect of the Programme on 1 July 2019, as supplemented on 23 July 2019, 9 August 2019, 30 October 2019 and 29 January 2020 (the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries only (as further specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus you must ascertain from the Final Terms and the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon your compliance with the above requirement.

 

This publication of the Final Terms does not constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFTXVLFLBLLFBBL
Date   Source Headline
17th Aug 20181:17 pmRNSForm 8.3 - Shire plc
17th Aug 20181:16 pmRNSForm 8.3 - Shire plc
17th Aug 20181:15 pmRNSForm 8.3 - Shire plc
14th Aug 20181:47 pmRNSPublication of Final Terms
10th Aug 20185:28 pmRNSPublication of Suppl.Prospcts
10th Aug 20187:15 amRNSHalf-year Report
10th Aug 20187:15 amRNSHalf-year Report
25th Jul 20182:24 pmRNSPublication of Suppl.Prospcts
25th Jul 20182:16 pmRNSPublication of Suppl.Prospcts
25th Jul 20187:15 amRNSQuarterly Management Statement - 30 June 2018
9th Jul 20184:24 pmRNSArticle 8
9th Jul 201812:02 pmRNSNotice of Delisting
25th Jun 201812:31 pmRNSPublication of Suppl.Prospcts
25th Jun 201812:26 pmRNSPublication of Suppl.Prospcts
13th Jun 201810:47 amRNSApproval of Ring-Fencing Transfer Scheme
31st May 201810:53 amRNSDirectorate Change
14th May 20182:24 pmRNSArticle 8
14th May 201811:29 amRNSNotice of Delisting - Series 1125
8th May 20184:21 pmRNSPublication of Final Terms
8th May 20183:26 pmRNSPublication of Final Terms
4th May 201812:41 pmRNSPublication of Final Terms
27th Apr 20184:47 pmRNSStatement re Change of Paying & Transfer Agent
27th Apr 201811:46 amRNSNotice Change of Agent
24th Apr 20186:15 pmRNSPublication of a Prospectus
24th Apr 20182:36 pmRNSPublication of Suppl.Prospcts
24th Apr 20187:15 amRNS1st Quarter Results
13th Apr 20182:16 pmRNSPublication of Final Terms
11th Apr 20184:49 pmRNSOffer period extension Series 1125-1126
29th Mar 201811:29 amRNSArticle 8
28th Mar 20185:11 pmRNSPublication of Final Terms
26th Mar 20184:27 pmRNSArticle 8
19th Mar 20182:29 pmRNSDelisting notice - Series 1121 - XS1710683985
19th Mar 201811:52 amRNSArticle 8
12th Mar 201810:40 amRNSCall notice XS0907246812. Series 790
9th Mar 20183:46 pmRNSPublication of Final Terms
2nd Mar 20184:31 pmRNSPre-Stab: Santander, GBP 50m Tap, due 27/02/2020
2nd Mar 20184:14 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:10 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:02 pmRNSPublication of Final Terms
2nd Mar 20183:58 pmRNSPublication of Final Terms
28th Feb 201812:45 pmRNSAnnual Financial Report
28th Feb 201812:40 pmRNSAnnual Financial Report
26th Feb 20185:20 pmRNSPublication of Final Terms
23rd Feb 20182:47 pmRNSArticle 8
22nd Feb 20185:34 pmRNSPre-Stab Notice - SANUK, GBP 250m, due 27/02/2020
12th Feb 201810:58 amRNSNotice of Early Redemption
7th Feb 20185:43 pmRNSPublication of Suppl.Prospcts
7th Feb 20185:39 pmRNSPublication of Suppl.Prospcts
6th Feb 201811:41 amRNSUpdate on Ring-fencing & Part VII Transfer Scheme
31st Jan 20187:15 amRNSQ4 17 - Quarterly Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.